Focus on antimicrobial use in the era of increasing antimicrobial resistance in ICU. (Q53791273)

19 May 2018

editorial

0 references

title

Focus on antimicrobial use in the era of increasing antimicrobial resistance in ICU. (English)

1 reference

19 May 2018

main subject

antimicrobial resistance

1 reference

1

Matteo Bassetti

1 reference

19 May 2018

Jean-François Timsit

series ordinal

3

object named as

Jean-François Timsit

1 reference

19 May 2018

author name string

Garyphallia Poulakou

series ordinal

2

1 reference

19 May 2018

publication date

4 April 2016

1 reference

19 May 2018

published in

Intensive Care Medicine

1 reference

19 May 2018

volume

42

1 reference

19 May 2018

page(s)

955-958

1 reference

19 May 2018

issue

6

1 reference

19 May 2018

https://scigraph.springernature.com/pub.10.1007/s00134-016-4341-4

exact match

0 references

cites work

Understanding the mechanisms and drivers of antimicrobial resistance.

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4341-4

Ten tips on how to win the war against resistance to antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4341-4

Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4341-4

Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4341-4

Task force on management and prevention of Acinetobacter baumannii infections in the ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4341-4

Understanding chlorhexidine decolonization strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4341-4

Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4341-4

Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4341-4

Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4341-4

A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4341-4

Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4341-4

Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4341-4

Tigecycline use in critically ill patients: a multicentre prospective observational study in the intensive care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4341-4

Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4341-4

A Systematic Review of the Definitions, Determinants, and Clinical Outcomes of Antimicrobial De-escalation in the Intensive Care Unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4341-4

De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4341-4

De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4341-4

DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4341-4

Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27043234

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27043234

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27043234

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00134-016-4341-4

1 reference

19 May 2018

PubMed ID

27043234

1 reference

19 May 2018